From the Alliance for Natural Health website:
Chronic hepatitis C affects 3 million Americans, is the leading cause of liver cancer and liver transplants, and kills 15,000 a year.
Unfortunately, the traditional “cure” for chronic hep C—interferon drugs—is almost as brutal as the disease. Interferon injections commonly cause flulike symptoms, anxiety, depression (in 31% of patients), nausea (43% of patients), diarrhea (22% of patients), and insomnia (40%).
But according to Big Pharma firm Gilead Sciences, they now have a breakthrough hep C treatment—Sovalidi—that will increase cure rates and slash the amount of time patients need to be on interferon. This drug, they say, will “have a major impact on public health” and mark “a new era” in hepatitis C treatment.
That may be true—for the few who can afford it.
Sovalidi costs $1,000 a day—that is, $1,000 per pill—which is between $84,000 and $189,000 per treatment course. With this pricing, Sovaldi is expected to earn its producer $2 billion in 2015 and $9 billion by 2017, making it the biggest-selling drug of all time.
There are countless reasons why America boasts the world’s highest drug prices, including reverse payments (legal bribes that prevent generics from entering the market) and the government-protected pharmaceutical monopoly over natural solutions.
Read more at Alliance for Natural Health